Home | 2 Minute Medicine
WEBAt-home misoprostol increases rate of day-care procedures and patient satisfaction in late medical abortion. by Neel Mistry and 1 others. September 10, 2024. 1. 71% of home group patients and 46% of hospital group patients completed abortion as a day-care procedure. 2. Majority of adverse events were mild-to-moderate with no fatalities reported.
The PROSEVA trial: Proning in severe ARDS [Classics Series]
WEBApr 17, 2015 · 1. In patients with severe acute respiratory distress syndrome (ARDS), prone-positioning significantly reduced 28-day and 90-day mortality when compared with patients remaining in supine position. 2. Proned patients were also successfully extubated at higher rates and required fewer days of ventilation when compared to supine patients. Original Date of Publication: June 2013 Study Rundown: The
Landmark Trials & Summaries: The Classics in Medicine - 2 Minute …
WEBA deep understanding of these trials is paramount for every physician, healthcare professional, and trainee, as it lays the foundation for evidence-based clinical decisions made daily. 2MM+ Subscriber Exclusive Access: The Online Edition of The Classics Series™ includes The Classics in Medicine™ textbook and all deep-dive sub-specialty ...
The Child-Pugh score: Prognosis in chronic liver disease and …
WEBDec 3, 2023 · 1. The Child-Pugh score consists of five clinical features and is used to assess the prognosis of chronic liver disease and cirrhosis. 2. The Child-Pugh score was originally developed in 1973 to predict surgical outcomes in patients presenting with bleeding esophageal varices.
Mediterranean diet effects on vascular health and serum levels of ...
WEBAug 15, 2024 · 1. The effect of the Mediterranean Diet on cardiovascular health can be partially explained by improved vascular health, lowered total cholesterol and LDL, lowered ceramides, and reduced serum inflammatory adipokines. Evidence Rating Level: 1 (Excellent) Study Rundown: The Mediterranean Diet has been previously shown to improve cardiovascular outcomes in patients. This is proposed to be
The UKPDS: Reducing diabetes-related morbidity and mortality …
WEBNov 9, 2014 · 1. For patients with type 2 diabetes mellitus, pharmacologic blood glucose control with sulfonylureas or insulin significantly reduces the risk of microvascular complications, but not macrovascular complications. 2. Metformin therapy is associated with significant reductions in diabetes-related and all-cause mortality; thus, it is considered first-line therapy for type 2 diabetes mellitus.
Patient Basics: Seizure - 2 Minute Medicine
WEBNov 30, 2014 · A seizure is a sudden change in the brain's normal electrical activity. During a seizure, brain cells "fire" uncontrollably at up to four times their normal rate, temporarily affecting the way a person behaves, moves, thinks or feels. There are two major types of seizures: Primary generalized seizures.
Patient Basics: Epiglottitis | 2 Minute Medicine
WEBNov 30, 2014 · Epiglottitis is a rare, but potentially life-threatening infection. It causes sudden swelling of the epiglottis, which often worsens rapidly, sometimes within hours. Without timely treatment, the epiglottis can become so large that it blocks the windpipe, making it hard to breathe. This can cause death. Epiglottitis can occur at any age.
Early intensive glycemic control reduces long-term risk of death …
WEBAug 15, 2024 · In-depth [randomized controlled trial]: Between 1977 and 1991, 5102 patients were screened for eligibility of which 1489 were ultimately included in the final analysis for the 14-year post-trial monitoring study. Included were patients with newly diagnosed type 2 diabetes (T2DM) who were assigned to either intensive glycaemic control or conventional glycaemic control.
The ABCD2 score: Risk of stroke after Transient Ischemic Attack …
WEBMar 1, 2023 · Previous Post Infant screen use is associated with alterations in neurocognitive measures Next Post Unclear utility of the European Society of Cardiology 0/1h troponin algorithm in diagnosing acute coronary syndrome in patients with known coronary artery disease